Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
DZU9Q5
|
|||
| Drug Name |
CAM-101
|
|||
| Drug Type |
Cell therapy
|
|||
| Indication | Keratoconjunctivitis sicca [ICD-11: 9A79] | Phase 1/2 | [1] | |
| Company |
Cambium Medical Technologies
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT03414645) Randomized Multicenter Double-Masked Placebo-Controlled Parallel Phase I/II Study to Determine the Safety and Exploratory Efficacy of Topical Fibrinogen Depleted Human Platelet Lysate in Patients With Dry Eye Secondary to Graft vs Host Disease. U.S.National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.